Hepatic Safety of Bedaquiline, Delamanid, and Pretomanid: A Systematic Review and Meta-analysis

Novel anti-tuberculosis (TB) drugs have been shown to effectively treat drug-resistant TB (DR-TB). However, there is a risk of hepatotoxicity. We aimed to evaluate the incidence of hepatotoxicity in TB patients receiving bedaquiline (BDQ), delamanid (DLM), and/or pretomanid (Pa). This meta-analysis...

Description complète

Détails bibliographiques

Auteurs principaux:	Mohamad Faisal Said Al Omar, Izz Eddin Majed Alchikhsuliman, Sondos Mahmoud Awad, Numa Rajab, Yousef Mohammed Alawi, Leena Yousif Mohamed Ibrahim, Idris Sula, Muhammad Candragupta Jihwaprani, Nazmus Saquib
Format:	Artigo
Langue:	Inglês
Publié:	Wolters Kluwer Medknow Publications 2025-10-01
Collection:	International Journal of Mycobacteriology
Sujets:	bedaquiline delamanid hepatotoxicity pretomanid tuberculosis
Accès en ligne:	https://journals.lww.com/10.4103/ijmy.ijmy_97_25
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!